Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T14:56:41.839Z.
Calculation as of: 2026-10-06T14:56:41.839Z.
Quote observation: 2026-10-06T14:55:25.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 5259cb07e2fbb96f0e8f0a81153900e7454c243d03e5865b91db876a0b9f3ffb
EARNINGS YIELD
N/A
Market Cap
$418.49M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$438.56M
Earnings Yield
2.49%
TTM Avg
1.91%
3Y Avg
1.91%
5Y Avg
1.91%
Market Cap
$410.54M
Earnings Yield
N/A
TTM Avg
8.82%
3Y Avg
5.78%
5Y Avg
5.78%
Market Cap
$445.94M
Earnings Yield
N/A
TTM Avg
49.38%
3Y Avg
49.38%
5Y Avg
49.38%
Market Cap
$446.57M
Earnings Yield
N/A
TTM Avg
1.29%
3Y Avg
1.29%
5Y Avg
1.29%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Editas Medicine, Inc. (EDIT) | $427.39M | N/A | N/A | N/A | N/A |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $418.49M | N/A | N/A | N/A | N/A |
| NeoGenomics, Inc. (NEO)vs › | $438.10M | N/A | 4.67% | 2.17% | 1.96% |
| Assembly Biosciences, Inc. (ASMB)vs › | $438.56M | 2.49% | 1.91% | 1.91% | 1.91% |
| NeuroPace, Inc. (NPCE)vs › | $440.84M | N/A | N/A | N/A | N/A |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $410.54M | N/A | 8.82% | 5.78% | 5.78% |
| Ovid Therapeutics Inc. (OVID)vs › | $445.94M | N/A | 49.38% | 49.38% | 49.38% |
| Shoulder Innovations, Inc. (SI)vs › | $408.34M | N/A | N/A | N/A | N/A |
| Capricor Therapeutics, Inc. (CAPR)vs › | $446.57M | N/A | 1.29% | 1.29% | 1.29% |
| Carlsmed, Inc. (CARL)vs › | $406.69M | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
